Clinical Trial

Role of Angiogenesis in Dermatologic Diseases

Study Description

Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

The researchers believe that pro-angiogenic factors are upregulated in a wide range of dermatologic diseases including port wine stains, hemangiomas, angiofibromas, Kaposi's sarcoma, angiosarcoma, scars, rosacea and psoriasis. The researcher can perform immunohistochemistry and/or microarray analysis and/or quantitative polymerase chain reaction on previously biopsied skin specimens and newly biopsied skin specimens to evaluate the expression of various angiogenic factors in these dermatologic diseases. In addition, some of the skin specimens may be utilized to make cell cultures to study expression of angiogenic factors and interactions of cells in dermatologic disease.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

skin tissue sample

skin tissue sample

Additional Information

Official Study Title

Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

Clinical Trial ID

NCT00842283

ParticipAid ID

zbqj2d